Paul Lucas

Paul Lucas

Chairman at
Luminex Molecular Diagnostics, Inc.

Net worth: 982 888 $ as of 2026-05-30

76 year
Health Technology
Commercial Services
Consumer Services

Profile

Paul N.
Lucas
is currently Chairman at Luminex Molecular Diagnostics, Inc., Vice Chairman at Pharmaceutical Manufacturers Association of Canada, Chairman at Induran Ventures, Inc., Director at Select Therapeutics, Inc. since 1998, and Director at Rna Diagnostics, Inc. Formerly, Mr. Lucas was President & Chief Executive Officer at GlaxoSmithKline, Inc. from 2000 to 2012, Chairman at EcoSynthetix, Inc. from 2016 to 2025, Chairman at VIVO Cannabis, Inc. from 2017 to 2020, Chairman at Tm Bioscience Corp., Canada's Research Based Pharmaceutical Cos., Innovative Medicines Canada, and Life Sciences Ontario.
Also held director roles at Biochem Pharma, Inc., The Toronto Region Research Alliance, Allergen NCE, Inc., Ontario Genomics Institute, Montreal Invivo Organization, ABcann Medicinals, Inc., and Strategic Regional Research Alliance.
Served as Principal at Eli Lilly Canada, Inc. and McNeil Pharmaceutical.
Served as Trustee at Queen's University and Member-Principal Advisory Council at The University of Toronto Mississauga.
Education includes undergraduate degree from Queen's University and undergraduate degree from The Directors College conferred in 2009.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2025-05-22 402,823 ( 0.68% ) 982 888 $ 2026-05-30

Paul Lucas active positions

CompaniesPositionStart
Chairman -
Director/Board Member 2010-02-21
Pharmaceutical Manufacturers Association of Canada
Director/Board Member 2010-02-21
Director/Board Member -
Chairman -

Former positions of Paul Lucas

CompaniesPositionEnd
ECOSYNTHETIX INC. Chairman 2025-05-21
VIVO CANNABIS INC. Chairman 2020-12-30
Chief Executive Officer 2012-05-31
Director/Board Member -
░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
See the detail of Paul Lucas's experience

Training of Paul Lucas

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

37

1st degree connections

24

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies24

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Services

McNeil Pharmaceutical

Health Technology

Commercial Services

Commercial Services

Pharmaceutical Manufacturers Association of Canada

Commercial Services

Commercial Services

Process Industries

Commercial Services

Consumer Services

Consumer Services

Health Technology

Process Industries

Process Industries

Strategic Regional Research Alliance

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!